A response playbook for early detection and population surveillance of new SARS-CoV-2 variants in a regional public health laboratory.
Disease outbreaks
Genomic surveillance
Infectious disease
Public health preparedness
Public health systems
SARS-CoV-2
Surveillance
Journal
BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562
Informations de publication
Date de publication:
02 Jan 2024
02 Jan 2024
Historique:
received:
27
07
2023
accepted:
19
12
2023
medline:
4
1
2024
pubmed:
4
1
2024
entrez:
3
1
2024
Statut:
epublish
Résumé
Timely genomic surveillance is required to inform public health responses to new SARS-CoV-2 variants. However, the processes involved in local genomic surveillance introduce inherent time constraints. The Regional Innovative Public Health Laboratory in Chicago developed and employed a genomic surveillance response playbook for the early detection and surveillance of emerging SARS-CoV-2 variants. The playbook outlines modifications to sampling strategies, laboratory workflows, and communication processes based on the emerging variant's predicted viral characteristics, observed public health impact in other jurisdictions and local community risk level. The playbook outlines procedures for implementing and reporting enhanced and accelerated genomic surveillance, including supplementing whole genome sequencing (WGS) with variant screening by quantitative PCR (qPCR). The ability of the playbook to improve the response to an emerging variant was tested for SARS-CoV-2 Omicron BA.1. Increased submission of clinical remnant samples from local hospital laboratories enabled detection of a new variant at an average of 1.4% prevalence with 95% confidence rather than 3.5% at baseline. Genotyping qPCR concurred with WGS lineage assignments in 99.9% of 1541 samples with results by both methods, and was more sensitive, providing lineage results in 90.4% of 1833 samples rather than 85.1% for WGS, while significantly reducing the time to lineage result. The genomic surveillance response playbook provides a structured, stepwise, and data-driven approach to responding to emerging SARS-CoV-2 variants. These pre-defined processes can serve as a template for other genomic surveillance programs to streamline workflows and expedite the detection and public health response to emerging variants. Based on the processes piloted during the Omicron BA.1 response, this method has been applied to subsequent Omicron subvariants and can be readily applied to future SARS-CoV-2 emerging variants and other public health surveillance activities.
Sections du résumé
BACKGROUND
BACKGROUND
Timely genomic surveillance is required to inform public health responses to new SARS-CoV-2 variants. However, the processes involved in local genomic surveillance introduce inherent time constraints. The Regional Innovative Public Health Laboratory in Chicago developed and employed a genomic surveillance response playbook for the early detection and surveillance of emerging SARS-CoV-2 variants.
METHODS
METHODS
The playbook outlines modifications to sampling strategies, laboratory workflows, and communication processes based on the emerging variant's predicted viral characteristics, observed public health impact in other jurisdictions and local community risk level. The playbook outlines procedures for implementing and reporting enhanced and accelerated genomic surveillance, including supplementing whole genome sequencing (WGS) with variant screening by quantitative PCR (qPCR).
RESULTS
RESULTS
The ability of the playbook to improve the response to an emerging variant was tested for SARS-CoV-2 Omicron BA.1. Increased submission of clinical remnant samples from local hospital laboratories enabled detection of a new variant at an average of 1.4% prevalence with 95% confidence rather than 3.5% at baseline. Genotyping qPCR concurred with WGS lineage assignments in 99.9% of 1541 samples with results by both methods, and was more sensitive, providing lineage results in 90.4% of 1833 samples rather than 85.1% for WGS, while significantly reducing the time to lineage result.
CONCLUSIONS
CONCLUSIONS
The genomic surveillance response playbook provides a structured, stepwise, and data-driven approach to responding to emerging SARS-CoV-2 variants. These pre-defined processes can serve as a template for other genomic surveillance programs to streamline workflows and expedite the detection and public health response to emerging variants. Based on the processes piloted during the Omicron BA.1 response, this method has been applied to subsequent Omicron subvariants and can be readily applied to future SARS-CoV-2 emerging variants and other public health surveillance activities.
Identifiants
pubmed: 38166805
doi: 10.1186/s12889-023-17536-0
pii: 10.1186/s12889-023-17536-0
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
59Informations de copyright
© 2023. The Author(s).
Références
Pei S, Yamana TK, Kandula S, Galanti M, Shaman J. Burden and characteristics of COVID-19 in the United States during 2020. Nature. 2021;598(7880):338–41. https://doi.org/10.1038/s41586-021-03914-4 .
doi: 10.1038/s41586-021-03914-4
pubmed: 34438440
Walensky RP, Walke HT, Fauci AS. SARS-CoV-2 variants of concern in the United States—challenges and opportunities. JAMA. 2021;325(11):1037–8. https://doi.org/10.1001/jama.2021.2294 .
doi: 10.1001/jama.2021.2294
pubmed: 33595644
pmcid: 9009864
Paul P, France AM, Aoki Y, et al. Genomic surveillance for SARS-COV-2 variants circulating in the United States, December 2020–May 2021. MMWR Morbidity and Mortality Weekly Report. 2021;70(23):846–50. https://doi.org/10.15585/mmwr.mm7023a3 .
doi: 10.15585/mmwr.mm7023a3
pubmed: 34111060
pmcid: 8191868
Doyle K, Teran RA, Reefhuis J, et al. Multiple variants of SARS-COV-2 in a university outbreak after Spring Break — Chicago, Illinois, March–May 2021. MMWR Morbidity and Mortality Weekly Report. 2021;70(35):1195–200. https://doi.org/10.15585/mmwr.mm7035a3 .
doi: 10.15585/mmwr.mm7035a3
pubmed: 34473687
pmcid: 8422867
Stoddard G, Black A, Ayscue P, et al. Using genomic epidemiology of SARS-COV-2 to support contact tracing and public health surveillance in rural Humboldt County, California. BMC Public Health. 2022;22(1). https://doi.org/10.1186/s12889-022-12790-0 .
Armstrong GL, MacCannell DR, Taylor J, et al. Pathogen genomics in public health. N Engl J Med. 2019;381(26):2569–80. https://doi.org/10.1056/nejmsr1813907 .
doi: 10.1056/nejmsr1813907
pubmed: 31881145
pmcid: 7008580
Lind A, Barlinn R, Landaas ET, et al. Rapid SARS-COV-2 variant monitoring using PCR confirmed by whole genome sequencing in a high-volume diagnostic laboratory. J Clin Virol. 2021;141:104906. https://doi.org/10.1016/j.jcv.2021.104906 .
doi: 10.1016/j.jcv.2021.104906
pubmed: 34273860
pmcid: 8262397
Wang H, Miller JA, Verghese M, et al. Multiplex SARS-COV-2 genotyping reverse transcriptase PCR for population-level variant screening and Epidemiologic Surveillance. J Clin Microbiol. 2021;59(8). https://doi.org/10.1128/jcm.00859-21 .
Harper H, Burridge A, Winfield M, Finn A, Davidson A, et al. Detecting SARS-CoV-2 variants with SNP genotyping. PLoS ONE. 2021;16(2):e0243185. https://doi.org/10.1371/journal.pone.0243185 .
Galloway SE, Paul P, MacCannell DR, et al. Emergence of SARS-COV-2 B.1.1.7 lineage — United States, December 29, 2020–January 12, 2021. MMWR Morbidity and Mortality Weekly Report. 2021;70(3):95–9. https://doi.org/10.15585/mmwr.mm7003e2 .
doi: 10.15585/mmwr.mm7003e2
pubmed: 33476315
pmcid: 7821772
Blomquist PB, Bridgen J, Bray N, et al. Enhancing epidemiological surveillance of the emergence of the SARS-COV-2 omicron variant using spike gene target failure data, England, 15 November to 31 December 2021. Eurosurveillance. 2022;27(11). https://doi.org/10.2807/1560-7917.es.2022.27.11.2200143 .
Scobie HM, Ali AR, Shirk P, et al. Spike gene target amplification in a diagnostic assay as a Marker for Public Health Monitoring of Emerging SARS-CoV-2 variants — United States, November 2021–January 2023. MMWR Morb Mortal Wkly Rep. 2023;72:125–7. https://doi.org/10.15585/mmwr.mm7205e2 .
doi: 10.15585/mmwr.mm7205e2
pubmed: 36730050
pmcid: 9927069
World Health Organization. (2021). Genomic sequencing of SARS-CoV-2: a guide to implementation for maximum impact on public health, 8 January 2021. World Health Organization. https://apps.who.int/iris/handle/10665/338480 . License: CC BY-NC-SA 3.0 IGO.
Grubaugh ND, Hodcroft EB, Fauver JR, Phelan AL, Cevik M. Public health actions to control new SARS-COV-2 variants. Cell. 2021;184(5):1127–32. https://doi.org/10.1016/j.cell.2021.01.044 .
doi: 10.1016/j.cell.2021.01.044
pubmed: 33581746
pmcid: 7846239
Nelson T, Kagan N, Critchlow C, Hillard A, Hsu A. The Danger of Misinformation in the COVID-19 Crisis. Mo Med. 2020;117(6):510–2.
pubmed: 33311767
pmcid: 7721433
Sample Size Calculator Detecting COVID-19 Variants - Variant Detection Calculator. The University of Texas at Austin. Accessed November 19, 2021. https://covid-19.tacc.utexas.edu/dashboards/variants/ .
Grubaugh ND, Gangavarapu K, Quick J, et al. An amplicon-based sequencing framework for accurately measuring intrahost virus diversity using PrimalSeq and Ivar. Genome Biol. 2019;20(1). https://doi.org/10.1186/s13059-018-1618-7 .
O’Toole Á, Scher E, Underwood A, et al. Assignment of epidemiological lineages in an emerging pandemic using the pangolin tool. Virus Evol. 2021. https://doi.org/10.1093/ve/veab064 .
doi: 10.1093/ve/veab064
pubmed: 34527285
pmcid: 8344591
Aksamentov I, Roemer C, Hodcroft E, Neher R, Nextclade. Clade assignment, mutation calling and quality control for viral genomes. J Open Source Softw. 2021;6(67):3773. https://doi.org/10.21105/joss.03773 .
doi: 10.21105/joss.03773
Paul P, France AM, Aoki Y, Batra D, Biggerstaff M, Dugan V, Galloway S, Hall AJ, Johansson MA, Kondor RJ, Halpin AL, Lee B, Lee JS, Limbago B, MacNeil A, MacCannell D, Paden CR, Queen K, Reese HE, Retchless AC, Slayton RB, Steele M, Tong S, Walters MS, Wentworth DE, Silk BJ. Genomic surveillance for SARS-CoV-2 variants circulating in the United States, December 2020-May 2021. MMWR Morb Mortal Wkly Rep. 2021;70(23):846–50. https://doi.org/10.15585/mmwr.mm7023a3 .
doi: 10.15585/mmwr.mm7023a3
pubmed: 34111060
pmcid: 8191868
Khare S, Gurry C, Freitas L, Schultz MB, Bach G, Diallo A, Akite N, Ho J, Lee RT, Yeo W, Curation Team GC, Maurer-Stroh S. GISAID’s role in Pandemic Response. China CDC Wkly. 2021;3(49):1049–51. https://doi.org/10.46234/ccdcw2021.255 .
doi: 10.46234/ccdcw2021.255
pubmed: 34934514
pmcid: 8668406
Chicago Health Alert Network. Enhanced SARS-CoV-2 strain surveillance for Omicron variant. Nov 30, 2021. https://www.chicagohan.org/alert-detail/-/alert-details/46669378 .
Spencer H, Teran RA, Barbian HJ, et al. Multistate outbreak of Infection with SARS-CoV-2 Omicron variant after event in Chicago, Illinois, USA, 2021. Emerg Infect Dis. 2022;28(6):1281–3. https://doi.org/10.3201/eid2806.220411 .
doi: 10.3201/eid2806.220411
pubmed: 35608888
pmcid: 9155870
Figgins MD, Bedford T. SARS-CoV-2 variant dynamics across US states show consistent differences in effective reproduction numbers. MedRxiv 2021.12.09.21267544. https://doi.org/10.1101/2021.12.09.21267544 .
Lai E, Kennedy EB, Lozach J, Hayashibara K, Davis-Turak J, Becker D, Brzoska P, Cassens T, Diamond E, Gandhi M, et al. A method for variant Agnostic detection of SARS-CoV-2, Rapid Monitoring of Circulating Variants, and early detection of Emergent variants such as Omicron. J Clin Microbiol. 2022;60(7):e0034222. https://doi.org/10.1128/jcm.00342-22 . Epub 2022 Jun 29.
doi: 10.1128/jcm.00342-22
pubmed: 35766514
Centers for Disease Control and Prevention. COVID Data Tracker. Atlanta, GA: U.S. Department of Health and Human Services, CDC; 2023, November 21. https://covid.cdc.gov/covid-data-tracker .